Treatment of malignant hypercalcaemia with clodronate (Q35992157)

11 August 2017

Treatment of malignant hypercalcaemia with clodronate (English)

1 reference

11 August 2017

Percival RC

1

1 reference

11 August 2017

Paterson AD

2

1 reference

11 August 2017

Yates AJ

3

1 reference

11 August 2017

Beard DJ

4

1 reference

11 August 2017

Douglas DL

5

1 reference

11 August 2017

Neal FE

6

1 reference

11 August 2017

Russell RG

7

1 reference

11 August 2017

Kanis JA

8

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 May 1985

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

51

1 reference

11 August 2017

5

1 reference

11 August 2017

665-669

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1985.100

11 August 2017

0 references

cites work

Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977044

Role of glucocorticoids in management of malignant hypercalcaemia.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977044

The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977044

Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977044

Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977044

Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977044

Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.)

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977044

Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977044

Treatment of hypercalcaemia associated with malignancy.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977044

Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977044

Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977044

Monitoring the treatment of Paget's disease with etidronate

11 July 2018

1 reference

12 December 2020

Hypercalcaemia--a hospital survey

1 reference

12 December 2020

Parenteral diphosphonates for treating malignant hypercalcemia

1 reference

12 December 2020

Clodronate kinetics and bioavailability

1 reference

12 December 2020

Rehydration in the treatment of severe hypercalcaemia

1 reference

12 December 2020

Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity

1 reference

12 December 2020

Comparative study of available medical therapy for hypercalcemia of malignancy

1 reference

12 December 2020

Therapy of malignancy-associated hypercalcemia: 1983

1 reference

12 December 2020

The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma

1 reference

12 December 2020

Effects of intravenous diphosphonates on renal function

1 reference

12 December 2020

Use of Dichloromethylene Diphosphonate in Metastatic Bone Disease

1 reference

12 December 2020

Plasma hydroxyproline in uremia: relationships with histologic and biological indices of bone turnover

1 reference

12 December 2020

Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1985.100

1 reference

11 August 2017

1 reference

11 August 2017

1 reference